Experts examine lessons learned from the history of emerging infectious diseases and how the field can prepare now to ensure a safe and sufficient blood supply during the next emerging pathogen event.
7 min read |Members Only |Feature
In this month's President's message, Jose Cancelas, MD, PhD, CABP, discusses safeguarding the blood system, ensuring both safety and sufficiency in the face of evolving threats.
2 min read |Open Access |President’s Message
Transfusion leaders discuss how Canada will move forward to ensure continued vein-to-vein safety and ongoing monitoring following the end of the country's historic hemovigilance program.
11 min read |Members Only |Feature
Tracy Antonelli shares her journey living with thalassemia and adopting three daughters from China with the same rare blood disorder.
7 min read |Open Access |Feature
A pioneer in blood safety during the HIV/AIDS epidemic, Edgar Engleman, MD, shaped screening efforts and laid the groundwork for cellular therapies used in cancer treatment.
9 min read |Open Access |Feature
Antonella Nai discusses the potential impact of her AABB-Foundation supported project and how it may shape future therapies for anemia in transfusion medicine and biotherapies.
5 min read |Open Access |AABB Foundation: Shaping the Industry
José Arnulfo Pérez-Carrillo discusses his efforts to advance blood safety in Colombia and the key to translating hemovigilance data into meaningful change.
7 min read |Open Access |White Coats
A plan to maintain optimal blood product labeling is an essential part of disaster preparedness.
2 min read |Members Only |Insider's View
Emily Wilson shares her inspiration for becoming a CABP and the importance of maintaining certification.
2 min read |Open Access |High Priority
If you understand how exercise affects your brain and emotions, you can use it as a practical tool to improve your daily life.
5 min read |Members Only |Be Well
"I share AABB’s mission and vision to improve the lives of individuals by making transfusions and biotherapies safe, available and effective throughout the world."
2 min read |Members Only |Membership Focus
Of Note: News stories from the field.
9 min read |Members Only |Of Note
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Jose Cancelas, MD, PhD, CABP
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement Officer
Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
